TY - JOUR
T1 - Early detection of necrosis in low-enhanced pancreatic parenchyma using contrast-enhanced computed tomography was a better predictor of clinical outcomes than pancreatic inflammation
T2 - A multicentric cohort study of severe acute pancreatitis
AU - Yamamoto, Tomonori
AU - Horibe, Masayasu
AU - Sanui, Masamitsu
AU - Sasaki, Mitsuhito
AU - Mizobata, Yasumitsu
AU - Esaki, Maiko
AU - Sawano, Hirotaka
AU - Goto, Takashi
AU - Ikeura, Tsukasa
AU - Takeda, Tsuyoshi
AU - Oda, Takuya
AU - Yasuda, Hideto
AU - Namiki, Shin
AU - Miyazaki, Dai
AU - Kitamura, Katsuya
AU - Chiba, Nobutaka
AU - Ozaki, Tetsu
AU - Yamashita, Takahiro
AU - Oshima, Taku
AU - Hirota, Morihisa
AU - Moriya, Takashi
AU - Shirai, Kunihiro
AU - Yamamoto, Satoshi
AU - Kobayashi, Mioko
AU - Saito, Koji
AU - Saito, Shinjiro
AU - Iwasaki, Eisuke
AU - Kanai, Takanori
AU - Mayumi, Toshihiko
N1 - Publisher Copyright:
© 2024 IAP and EPC
PY - 2024/9
Y1 - 2024/9
N2 - Objectives: We aim to assess the early use of contrast-enhanced computed tomography (CECT) of patients with severe acute pancreatitis (SAP) using the computed tomography severity index (CTSI) in prognosis prediction. The CTSI combines quantification of pancreatic and extrapancreatic inflammation with the extent of pancreatic necrosis. Methods: Post-hoc retrospective analysis of a large, multicentric database (44 institutions) of SAP patients in Japan. The area under the curve (AUC) of the CTSI for predicting mortality and the odds ratio (OR) of the extent of pancreatic inflammation and necrosis were calculated using multivariable analysis. Results: In total, 1097 patients were included. The AUC of the CTSI for mortality was 0.65 (95 % confidence interval [CI:] [0.59–0.70]; p < 0.001). In multivariable analysis, necrosis 30–50 % and >50 % in low-enhanced pancreatic parenchyma (LEPP) was independently associated with a significant increase in mortality, with OR 2.04 and 95 % CI 1.01–4.12 (P < 0.05) and OR 3.88 and 95 % CI 2.04–7.40 (P < 0.001), respectively. However, the extent of pancreatic inflammation was not associated with mortality, regardless of severity. Conclusions: The degree of necrosis in LEPP assessed using early CECT of SAP was a better predictor of mortality than the extent of pancreatic inflammation.
AB - Objectives: We aim to assess the early use of contrast-enhanced computed tomography (CECT) of patients with severe acute pancreatitis (SAP) using the computed tomography severity index (CTSI) in prognosis prediction. The CTSI combines quantification of pancreatic and extrapancreatic inflammation with the extent of pancreatic necrosis. Methods: Post-hoc retrospective analysis of a large, multicentric database (44 institutions) of SAP patients in Japan. The area under the curve (AUC) of the CTSI for predicting mortality and the odds ratio (OR) of the extent of pancreatic inflammation and necrosis were calculated using multivariable analysis. Results: In total, 1097 patients were included. The AUC of the CTSI for mortality was 0.65 (95 % confidence interval [CI:] [0.59–0.70]; p < 0.001). In multivariable analysis, necrosis 30–50 % and >50 % in low-enhanced pancreatic parenchyma (LEPP) was independently associated with a significant increase in mortality, with OR 2.04 and 95 % CI 1.01–4.12 (P < 0.05) and OR 3.88 and 95 % CI 2.04–7.40 (P < 0.001), respectively. However, the extent of pancreatic inflammation was not associated with mortality, regardless of severity. Conclusions: The degree of necrosis in LEPP assessed using early CECT of SAP was a better predictor of mortality than the extent of pancreatic inflammation.
KW - Contrast-enhanced computed tomography
KW - Low-enhanced pancreatic parenchyma
KW - Pancreatic inflammation
KW - Pancreatic necrosis
KW - Severe acute pancreatitis
UR - http://www.scopus.com/inward/record.url?scp=85198188909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198188909&partnerID=8YFLogxK
U2 - 10.1016/j.pan.2024.07.001
DO - 10.1016/j.pan.2024.07.001
M3 - Article
C2 - 38991872
AN - SCOPUS:85198188909
SN - 1424-3903
VL - 24
SP - 827
EP - 833
JO - Pancreatology
JF - Pancreatology
IS - 6
ER -